Search tips
Search criteria

Results 1-3 (3)

Clipboard (0)
Year of Publication
1.  Author's reply 
Annals of Thoracic Medicine  2010;5(1):55-56.
PMCID: PMC2841815  PMID: 20351966
2.  Mycobacterium chelonae empyema with bronchopleural fistula in an immunocompetent patient 
Annals of Thoracic Medicine  2009;4(4):213-215.
Mycobacterium chelonae is one of the rapidly growing mycobacteria that rarely cause lung disease. M chelonae more commonly causes skin and soft tissue infections primarily in immunosuppressed individuals. Thoracic empyema caused by rapidly growing mycobacteria and complicated with bronchopleural fistula is rarely reported, especially in immunocompetent patients. In this article we report the first immunocompetent Arabian patient presented with M chelonae-related empyema with bronchopleural fistula which mimics, clinically and radiologically, empyema caused by Mycobacterium tuberculosis.
PMCID: PMC2801048  PMID: 19881169
Bronchopleural fistula; empyema; Mycobacterium chelonae; nontuberculous mycobacteria; rapidly growing mycobacteria
3.  Update on pleural diseases - 2007 
Annals of Thoracic Medicine  2007;2(3):128-142.
New information is available on pleural diseases. The authors selected articles to make recommendations on diagnostic and treatment aspects of pleural diseases.
Eleven articles published in the English language between 2004 and 2007 were chosen. The basis of selection of the articles was the impact on daily practice, change in prior thinking of a disease process or specific treatment modality, as well as proper design and execution of the study. 5-amino-laevulinic acid with fluorescent light combined with white light may allow further diagnostic yield in undiagnosed pleural disease. FDG-PET may allow prognostication of patients with pleural tumors. Utilizing ultrasound by trained Emergency Department physicians is a rapid and effective technique to evaluate non-traumatic pleural effusions in symptomatic patients. Serum osteopontin levels may distinguish patients exposed to asbestos with benign disease from those with pleural mesothelioma. Administration of streptokinase in patients with empyema does not need for surgical drainage, length of hospital stay, or mortality as compared to conventional treatment with chest tube drainage and intravenous antibiotics. Silver nitrate may be an alternative agent to talc for producing pleurodesis. Routine use of graded talc (50% particles greater than 25 microns) is recommended to reduce the morbidity associated with talc pleurodesis. Study design does not permit us to conclude that aspiration of spontaneous pneumothorax is as effective as chest tube drainage. Pleural catheter may prove to be an important palliative modality in treating debilitated patients or patients with trapped lung who show symptomatic improvement with drainage; however, at the present time, these catheters cannot be considered a first line treatment option for patients with malignant pleural effusion. One of the studies reviewed showed no significant difference in tract metastasis in patients with malignant mesothelioma undergoing an invasive pleural procedure with or without irradiation to the procedure site. However, the design of the trial does not allow us to make this conclusion at the present time.
PMCID: PMC2732091  PMID: 19727362
Pleural; empyema; effusions; mesothelioma; ultrasound; pleurodesis; pneumothorax; thoracoscopy

Results 1-3 (3)